Urothelial Cancer
(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)
- Details
ClinicalTrials.gov ID:
NCT03390504
Diagnosis Type:
NA
USOR Number:
- Address
310 Smith Ave N
Suite 100
Saint Paul, MN 55102
P: (651) 251-5500